Andra AP fonden Has $17.06 Million Holdings in Agilent Technologies, Inc. $A

Andra AP fonden increased its stake in Agilent Technologies, Inc. (NYSE:A) by 32.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 132,900 shares of the medical research company’s stock after purchasing an additional 32,600 shares during the quarter. Andra AP fonden’s holdings in Agilent Technologies were worth $17,058,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Resona Asset Management Co. Ltd. increased its stake in Agilent Technologies by 6.2% in the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares during the period. Envestnet Asset Management Inc. boosted its stake in Agilent Technologies by 3.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after buying an additional 22,498 shares in the last quarter. CCLA Investment Management boosted its stake in Agilent Technologies by 10.5% in the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after buying an additional 97,312 shares in the last quarter. Osaic Holdings Inc. grew its stake in Agilent Technologies by 35.5% during the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock worth $8,017,000 after buying an additional 17,817 shares during the last quarter. Finally, Nuance Investments LLC increased its holdings in shares of Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after buying an additional 9,628 shares in the last quarter.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Management raised FY‑2026 revenue ambition to $7.3B–$7.5B and highlighted expansion of its Ignite operating system as a path to future margin improvement. Read More.
• Positive Sentiment: Most sell‑side firms remain constructive (buy/overweight) and retain multi‑quarter price targets well above the current level despite trimming targets this week — supporting medium‑term upside if growth/margins recover. Read More.
• Neutral Sentiment: Agilent issued Q2 FY2026 EPS guidance of $1.39–1.42 and FY EPS of $5.90–6.04, which sits roughly around Street expectations — guidance is not a major beat or miss. Read More.
• Neutral Sentiment: Q4/CY2025 results were reported in line with expectations earlier, so the current reaction is focused on Q1 specifics and forward execution rather than a broader trend break. Read More.
• Negative Sentiment: Q1 results narrowly missed: EPS $1.36 vs. $1.37 consensus and revenue ~$1.80B vs. ~$1.81–1.84B estimates — the miss (and a weak margin cadence) triggered a near‑term selloff in earnings reaction. Read More.
• Negative Sentiment: Management said a severe U.S. winter storm disrupted shipments and service in the quarter, pressuring near‑term revenue and gross margins — investors may see this as a risk to near‑term execution. Read More.
• Negative Sentiment: Operating profit and operating cash flow declined year‑over‑year (cash from operations down notably), which raises short‑term concerns about margin leverage and free‑cash‑flow conversion. Institutional trimming noted in recent filings adds to near‑term selling pressure. Read More.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $121.08 on Friday. The stock’s 50 day moving average is $134.67 and its 200 day moving average is $135.91. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The firm has a market cap of $34.25 billion, a P/E ratio of 26.73, a P/E/G ratio of 3.51 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The firm had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a return on equity of 24.95% and a net margin of 18.26%.The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s payout ratio is presently 22.52%.

Analyst Ratings Changes

A has been the topic of several recent analyst reports. Bank of America boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Morgan Stanley started coverage on Agilent Technologies in a research note on Tuesday, December 2nd. They issued an “overweight” rating on the stock. Robert W. Baird increased their price objective on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Finally, Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $161.29.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.